N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide

C28H32ClN7O2S — CID 137351958

IUPACN-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide
SMILESCCc1cc(NS(=O)(=O)c2ccccc2Cl)nnc1-c1cc(CC)c2nc(NC3CCC(N)CC3)ncc2c1
InChIInChI=1S/C28H32ClN7O2S/c1-3-17-13-19(14-20-16-31-28(33-26(17)20)32-22-11-9-21(30)10-12-22)27-18(4-2)15-25(34-35-27)36-39(37,38)24-8-6-5-7-23(24)29/h5-8,13-16,21-22H,3-4,9-12,30H2,1-2H3,(H,34,36)(H,31,32,33)
InChIKeyXVDSBRYCJAZLHF-UHFFFAOYSA-N
MW566.13 g/mol
LogP5.35
Rot. Bonds8

About N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide

N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide (PubChem CID 137351958) has the molecular formula C28H32ClN7O2S and a molecular weight of 566.13 g/mol. Its IUPAC name is N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide.

Molecular Properties

Compound NameN-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide
PubChem CID137351958
Molecular FormulaC28H32ClN7O2S
Molecular Weight566.13 g/mol
Exact Mass565.20
IUPAC NameN-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide
SMILESCCc1cc(NS(=O)(=O)c2ccccc2Cl)nnc1-c1cc(CC)c2nc(NC3CCC(N)CC3)ncc2c1
InChIInChI=1S/C28H32ClN7O2S/c1-3-17-13-19(14-20-16-31-28(33-26(17)20)32-22-11-9-21(30)10-12-22)27-18(4-2)15-25(34-35-27)36-39(37,38)24-8-6-5-7-23(24)29/h5-8,13-16,21-22H,3-4,9-12,30H2,1-2H3,(H,34,36)(H,31,32,33)
InChIKeyXVDSBRYCJAZLHF-UHFFFAOYSA-N
XLogP5.35
TPSA135.78 Ų
H-Bond Donors3
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500566.13
LogP ≤ 55.35
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 108

Analyze N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide?
The IUPAC name of N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide (CID 137351958) is N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide.
What is the SMILES notation for N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide?
The canonical SMILES for N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide is CCc1cc(NS(=O)(=O)c2ccccc2Cl)nnc1-c1cc(CC)c2nc(NC3CCC(N)CC3)ncc2c1.
What is the InChIKey of N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide?
The InChIKey is XVDSBRYCJAZLHF-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H32ClN7O2S/c1-3-17-13-19(14-20-16-31-28(33-26(17)20)32-22-11-9-21(30)10-12-22)27-18(4-2)15-25(34-35-27)36-39(37,38)24-8-6-5-7-23(24)29/h5-8,13-16,21-22H,3-4,9-12,30H2,1-2H3,(H,34,36)(H,31,32,33).
What are the key properties of N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide?
N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide has a molecular weight of 566.13 g/mol, XLogP of 5.35, 8 rotatable bonds, 3 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[6-[2-[(4-aminocyclohexyl)amino]-8-ethylquinazolin-6-yl]-5-ethylpyridazin-3-yl]-2-chlorobenzenesulfonamide is sourced from PubChem (CID 137351958), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).